Search hospitals > Minnesota > New Ulm
New Ulm Medical Center
Claim this profileNew Ulm, Minnesota 56073
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
268 reported clinical trials
9 medical researchers
Summary
New Ulm Medical Center is a medical facility located in New Ulm, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. New Ulm Medical Center is involved with conducting 268 clinical trials across 440 conditions. There are 9 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
David M. KingRegions Hospital7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
91 reported clinical trials
154 drugs studied
Daniel M. AndersonAbbott-Northwestern Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
59 reported clinical trials
107 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
29 reported clinical trials
72 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at New Ulm Medical Center
Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Tumors
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at New Ulm Medical Center?
New Ulm Medical Center is a medical facility located in New Ulm, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. New Ulm Medical Center is involved with conducting 268 clinical trials across 440 conditions. There are 9 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.